SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-316059
Filing Date
2019-12-17
Accepted
2019-12-17 14:27:33
Documents
7
Period of Report
2019-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d849242d8k.htm 8-K 20957
2 EX-1.1 d849242dex11.htm EX-1.1 210646
3 EX-5.1 d849242dex51.htm EX-5.1 16285
4 EX-99.1 d849242dex991.htm EX-99.1 16578
5 GRAPHIC g849242g1217074427025.jpg GRAPHIC 1810
6 GRAPHIC g849242g1217074427305.jpg GRAPHIC 3013
7 GRAPHIC g849242snap0002.jpg GRAPHIC 10976
  Complete submission text file 0001193125-19-316059.txt   288289
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 191289332
SIC: 2836 Biological Products, (No Diagnostic Substances)